Hims & Hers Health (HIMS) Cash from Financing Activities (2019 - 2026)

Hims & Hers Health has reported Cash from Financing Activities for 8 years, with the latest figure at -$77.9 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 238.34% year-over-year to -$77.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $674.8 million (up 771.03% YoY) and the FY2025 annual result came in at $729.6 million, up 776.55% from the prior year.
• Cash from Financing Activities improved to -$77.9 million in Q1 2026 per HIMS's latest filing, from -$97.5 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $889.2 million in Q2 2025 and troughed at -$97.5 million in Q4 2025.
• A 5-year average of $29.4 million and a median of -$13.7 million in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities slumped 13308.97% in 2022, then soared 3647.45% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$10.5 million in 2022, then soared by 62.11% to -$4.0 million in 2023, then plunged by 244.49% to -$13.7 million in 2024, then plunged by 614.34% to -$97.5 million in 2025, then rose by 20.14% to -$77.9 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$77.9 million, -$97.5 million, and -$39.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.